Reaction Details |
| Report a problem with these data |
Target | Receptor-interacting serine/threonine-protein kinase 2 |
---|
Ligand | BDBM372165 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | RIPK2 Inhibition Assay |
---|
IC50 | <100±n/a nM |
---|
Citation | Laufer, R; Ng, G; Brokx, R; Pauls, HW; Li, S; Mason, JM; Bray, MR RIPK2 inhibitors and method of treating cancer with same US Patent US10239881 Publication Date 3/26/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Receptor-interacting serine/threonine-protein kinase 2 |
---|
Name: | Receptor-interacting serine/threonine-protein kinase 2 |
Synonyms: | CARDIAK | RICK | RIP2 | RIPK2 | RIPK2_HUMAN | Serine/threonine-protein kinase RIPK2 | Tyrosine-protein kinase RIPK2 | receptor-interacting serine/threonine-protein kinase 2 |
Type: | Protein |
Mol. Mass.: | 61201.30 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 540 |
Sequence: | MNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSER
KDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPL
RFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRS
SKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMY
SVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEI
TFLEAVIQLKKTKLQSVSSAIHLCDKKKMELSLNIPVNHGPQEESCGSSQLHENSGSPET
SRSLPAPQDNDFLSRKAQDCYFMKLHHCPGNHSWDSTISGSQRAAFCDHKTTPCSSAIIN
PLSTAGNSERLQPGIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTK
PTRTSKVRQLLDTTDIQGEEFAKVIVQKLKDNKQMGLQPYPEILVVSRSPSLNLLQNKSM
|
|
|
BDBM372165 |
---|
n/a |
---|
Name | BDBM372165 |
Synonyms: | N-(4-((4- methylpiperazin-1- yl)methyl)phenyl)- 6-(o-tolyl)-5H- pyrrolo[3,2-d] pyrimidin-2-amine | US10239881, Example A18 | US10875863, Example A18 |
Type | Small organic molecule |
Emp. Form. | C25H28N6 |
Mol. Mass. | 412.53 |
SMILES | CN1CCN(Cc2ccc(Nc3ncc4[nH]c(cc4n3)-c3ccccc3C)cc2)CC1 |
Structure |
|